2. Immunobiology of
IgE and IgE Receptors
History
IgE VS Parasite
Sites of IgE Production
IgE Structure & Mechanism of
Isotype Switching
IgE Receptors (FcRI, CD23)
3. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
Introduction
IgE is unique among immunoglobulin isotypes
● Induce very rapid biologic responses
● Extremely sensitive immunologic amplifier, triggering reactions on exposure
to minute quantities of antigen
● IgE receptors: FcεRI and CD23
● Effector cell lineages: mast cells and basophils
● Immune response: controlling infestation with helminths in parasite-
endemic regions
● Occurs in individuals with atopic conditions of eczema, allergic rhinitis, and
asthma
4. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
Introduction
IgE functions:
● Triggering acute allergic reactions
● Immune homeostasis
● IgE antibodies regulate IgE receptor expression
● Enhance allergen uptake by antigen-presenting cells
● Modulate mast cell survival, and facilitate antigen transport across intestinal
and respiratory epithelia
5. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
Introduction
• Of the five isotypes, IgE present in the smallest quantity (0.002% of circulating
immunoglobulins)
• Serum concentrations of IgE - nanograms (ng) or international units (IU) per
volume of serum (e.g., IU/mL, kIU/L)
1 IU is equal to 2.44 ng of protein
• IgE has highest affinity for antigens and its receptors
• Even low (ng/mL) concentrations of cell surface IgE can cause life-threatening
reactions by tremendous biologic amplification of IgE and its receptors
7. History
• In 1921, when Heinz Küstner’s serum (who had been highly allergic to fish) was
injected into Otto Prausnitz’s skin, the immediate sensitivity to fish was
transferred to the site “Prausnitz-Küstner (PK) reaction”
• A serum component was responsible for passively transferring the specific
sensitivity
• Substance = reagin
• Sera containing reagins = reaginic
• Local injection of serum could sensitize skin
for 2 weeks or more reagins must be
binding to high-affinity receptor
Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
T.A.E. Platts-Mills. Ann Allergy Asthma Immunol 2019;122:2−7.
8. History
• In 1968, revealed a new immunoglobulin class and the name IgE (E for
“erythema”) by Ishizakas in the United States, Bennich and Johansson in
Sweden, and Stanworth in England
Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
Toshiaki K. et al. The Journal of Immunology 2016;197: 4187-92.
9. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
IgE in Parasitic Immunity
• Presence of high IgE levels in populations residing in helminth-endemic regions
• IgE - controlling the host-parasite interaction
• IgE could opsonize Schistosoma mansoni for killing by human eosinophils and
even platelets, enhances granuloma formation in the liver while assisting in the
clearance of adult worms
• IgE accelerates the removal of adult Trichinella spiralis worms from the intestine
and mediates the destruction of tissue cysts
10.
11. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
Sites of IgE Production
Generation of high-affinity IgG responses and B cell memory is dependent on the
germinal center reaction in secondary lymphoid tissues
1. DCs (in respiratory, GI mucosa, skin) first recognize antigens
2. DCs express IgE receptors FcεRI and CD23, allergen uptake is facilitated in
the presence of specific IgE antibodies
3. Activated DCs display increased MHC class II molecules and express
chemokine receptor CCR7 regional lymph nodes
4. In lymph nodes, B cells in follicles engage & interact with activated T cells (by
DCs) activation of IL-4 and IL-4R, and CD40L (CD154)–CD40 signaling
germinal center formation - - - specialized follicular T helper (TFH) cells
(CXCR5+ and ICOS+) and Th2–like TFH cells help for IgE responses
12.
13. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
Sites of IgE Production
5. In germinal centers, B cells expand and are induced to activate somatic
hypermutation AID–dependent genetic process
6. B cell clones which these mutations confer higher antigen affinity are
selectively expanded affinity maturation
7. Specific cytokine and costimulatory signals drive isotype switching in the
germinal centers
IgE can be produced especially in mucosal-associated lymphoid tissues (e.g.,
Waldeyer tonsillar ring)
14. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
• Evidence of IgE switching in the mucosa: detection of IL-4, CD40L, BAFF,
AID, ε-germline transcripts, switch excision circles, and IgE+ plasma cells at
mucosa
• Some of this tissue IgE switching may actually be T cell-independent
• Increased IgE levels in patients with T cell deficiencies
• Bacterial superantigens encountered at mucosal surfaces - help drive IgE+ B
cell expansion
Sites of IgE Production
15. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
IgE Structure and Mechanisms of IgE
Isotype Switching
• Serum concentration of IgE
in normal individuals: 50-100
ng/mL (IgG: 5-10 mg/mL)
• Very short half-life (1-5 days)
in circulation - small number
of B cells committed to IgE
synthesis and by its localized
production at tissue sites
(bound to FcεRI on mast cells
and persist for months)
20. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
FcεRI, the High-Affinity IgE Receptor
• Majority of the systemic pool of IgE exists already tightly affixed
to effector cells in tissues by IgE receptors
Two forms of FcεRI:
• Tetrameric αβγ2 - on mast cells and basophils immediate
hypersensitivity
• Trimeric αγ2 - on Langerhans cells of skin and several DCs
(eosinophils, neutrophils, platelets, and epithelial cells of the
gastrointestinal and respiratory systems) FcεRI-mediated
antigen uptake by APCs
• FcεRI α chain - IgE binding
• FcεRI γ chain - signal transduction, contains tandem repeats
ITAMs, targets for phosphorylation by receptor-associated
tyrosine kinases
• FcεRI β chain - contains ITAMs and serve as chaperone for α
chain and amplify early events in FcεRI signaling
21. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
FcεRI Signaling Pathways
22. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
Negative Feedback in FcεRI Signaling
• Inhibitory mechanisms are triggered in parallel with activating pathways
• Downstream of kinase (DOK) family of proteins assemble to recruit inhibitory
elements, including RAS-GAP, (an RAS GTPase), SHIP-1 (SH2 inositol 5′-
phosphatase), and CSK (cSRC tyrosine kinase), which phosphorylates the
inhibitory/regulatory site on LYN and other SRC-family kinases
23. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
Soluble FcεRI
• Circulating soluble form of FcεRI-α (sFcεRI, about 40 kD)
• Which cell types releasing soluble receptor? and conditions leading to release?
• Functions of sFcεRI-α: block mast cell and basophil activation potential
functions in downregulation of allergic responses
24. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
Antigen-Independent
IgE-Mediated FcεRI Activation
• FcεRI occupied by IgE = a “loaded gun” ready to fire but inert before
allergen encounter
• In some circumstances FcεRI occupied by IgE - sufficient to induce signaling
events and stimulate cytokine release by mast cells = “cytokinergic”
25. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
IgE-Independent Immediate Hypersensitivity
• Animal models: IgE-independent IgG-mediated immediate hypersensitivity
• IgG1 can mediate anaphylaxis in mice through both mast cells and mast cell–
independent pathways
• Requires IgG receptor FcγRIII, IgG and FcγRIII - so much weaker than IgE and
FcεRI that concentrations of IgG and antigen required for IgE-independent
anaphylaxis are not normally observed outside the lab
26. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
IgE Levels Regulate FCεRI
• Binding of IgE to FcεR1 stabilizes the receptor, preventing internalization and
protease degradation
• Depletion of circulating free IgE by treatment with anti-IgE therapeutic
omalizumab decreased FcεRI levels on mast cells, basophils and DCs
• Anti-IgE therapy significant reduction in FcεRI levels and allergen sensitivity
of the effector cells of immediate hypersensitivity
27. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
IgE and Mast Cell Homeostasis
• IgE - modulate mast cell proliferation and survival
• Protects them from cell death by inducing expression of antiapoptotic factors
• IgE-FcεRI interactions provoke mast cell expansion
28. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
CD23, the Low-Affinity IgE Receptor
• CD23 - not a member of the Ig superfamily, instead belonging to C-type lectin family
• Each monomer consisting of a long extracellular α-helical coiled-coil stalk, which is
abundantly N-glycosylated, terminating in a globular head domain that binds to IgE
• Only oligomeric CD23 bind to IgE
• IgE-binding heads of CD23 can be cleaved by proteases, including allergens (e.g., Der
p 1 protease of dust mites) and endogenous ADAM family of proteases, ADAM8, -10,
and -33
• Liberated CD23 heads after cleaved, referred as soluble CD23 (sCD23), retain IgE-
binding capacity
29. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
CD23, the Low-Affinity IgE Receptor
CD23 expression stimulated by cytokines (IL-4, IL-5, IL-13, GM-CSF), CD40L
(CD154), and TLR ligands including lipopolysaccharide (LPS)
Functions:
• Facilitated uptake by various cell types and regulation of B cell function
• Mediating transport of antigen across epithelium (GI, respiratory) to basal surface
gains access to APCs and lymphocytes (protects food allergens from
degradation before their interaction with mucosal immune cells)
• Regulate IgE synthesis and allergic inflammation:
• Engagement of membrane form of CD23 on B cells suppresses IgE
production
• Alternatively, CD23 bind both IgE and CD21 IgE-inducing effect
30. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
CD23, the Low-Affinity IgE Receptor
31. Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
Galectin-3 and Macrophage Activation
• Galectin-3: lectin-family pentameric secreted protein
• Present at cell surfaces, major source of secreted galectin-3 is macrophages
• Bind both to IgE and to FcεRI dependent on glycosylation state
• No specific functions to the IgE-FcεRI system, but present at sites of
inflammation and its potent ability to activate mast cells through FcεRI cross-
linking (regardless of IgE occupancy of receptor) might exert important
functions in allergic pathogenesis
32. IgE Receptors
and Antigen-Presenting Cell Function
• Both FcεRI and CD23 are expressed on APCs and can mediate uptake of
allergen bound to IgE for processing and presentation to CD4+ Th cells
• Studies of cells in the skin of patients with atopic dermatitis: several FcεRI+ APC
populations, including Langerhans cells and inflammatory dendritic epidermal
cells
• FcεRI is highly upregulated on these cell types during allergic flares
Hans C. Oettgen. Middleton’s Allergy. 8th Ed.;2013:364-77.
34. Jeff Stokes, et al. UpToDate 2019.
Total IgE
• Sandwich-type assay
• Anti-IgE antibody is bound to a solid support
• Serum from a patient is added
• Unbound protein washed away
• Second labeled anti-IgE antibody added, and amount bound to the patient's IgE is
measured
1 international unit/mL = 2.44 ng/mL
35. Jeff Stokes, et al. UpToDate 2019.
Allergen-Specific IgE
• First commercial assay for allergen-specific IgE = radioallergosorbent test (RAST)
• Bound allergen-specific IgE detected with radioiodinated polyclonal antihuman IgE
and quantified with a gamma counter
• Modern methods use enzymes instead of radionucleotides
36. Jeff Stokes, et al. UpToDate 2019.
Allergen-Specific IgE
• The terms "in vitro IgE antibody assay" or "allergen-specific IgE immunoassay"
more accurately characterize the three IgE antibody assays clinically available in
North America:
●The HYTEC-288 - colorimetric assay using a paper disc solid-phase support. It is
being replaced by the Falcon autoanalyzer
●The ImmunoCAP - fluoroimmunoassay with a cellulose sponge solid-phase
matrix
●The Immulite chemiluminescent assay - biotinylated allergen and avidin particle
solid phase
• These three autoanalyzers use extracts from different sources immobilized as the
antigen capture allergosorbent, their results are not interchangeable
38. Clinical Significance of Immunoglobulin E
Normal IgE Production
IgE in Allergic Disease
IgE in Infectious Disease
IgE in Non Atopic Disease
Environmental Exposure & IgE
39. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
Normal IgE Production
IgE concentrations can be altered by disease processes through 4
mechanisms:
1. Total serum IgE levels can reflect nonspecific changes in protein production
or catabolism
2. Total serum IgE concentrations can reflect the balance or overall regulation
of the immune system
3. In some diseases, factors specifically stimulate IgE production
4. Some diseases may result directly from the production of IgE antibodies
specific for certain allergens
40. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
Ontogeny of IgE Production
GA 7-10 weeks: Germline transcripts for the ε chain of IgE detectable
GA 11 weeks: IgE production observed in human fetal tissue cultures
GA 20 weeks: B cells primed to undergo class switching can produce IgE
• Limited IgE production apparently correlates with limited fetal antigenic
exposure
• <1% of cord serum samples contain detectable IgE antibodies to common
allergens
• Most studies failed to find fetal IgE production in the absence of maternal
production
• Serum IgE concentrations gradually increase after birth, reach maximum values
between the ages of 10-15 years, decline throughout adulthood
41. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
42. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
Normal IgE Concentrations
• High upper limits of normal and broad overlap between IgE concentrations in atopic and
nonatopic people limit the diagnostic value of total serum IgE measurements for
detecting allergic disease
• Serum IgE levels influenced by age, genetic predisposition, race, immune status,
season of the year, medications, and some disease processes
• Racial factors - consistently higher IgE serum levels in blacks in all age groups, presumably
because of genetic differences and differences in environmental exposures
• Total serum IgE levels may vary twofold - fourfold annually in sensitive patients in pollen
seasons, reached maximum IgE at 4 to 6 weeks after peak of the pollen season, then
gradual decline until onset of next pollen season
43. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
• Most clinical assays for total IgE have a lower limit of detection of 2 to 5 IU/mL
• Concentrations of less than 2 IU/mL - reported as undetectable
• Undetectable concentrations of IgE might be related to autoimmune disease or
recurrent infections
Normal IgE Concentrations
44. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
IgE in Other Body Fluids
• Total and some allergen-specific IgE levels
• Nasal and bronchial washings, nasal polyp tissue, intestinal fluids, feces, saliva, breast milk,
urine, tears, middle ear effusions, aqueous humor, and cerebrospinal fluid
• Typically at concentrations of <1% of serum concentration
• Local production of IgE in tissues in whom circulating IgE of same specificity could not be
demonstrated clinical significance of local production has not been well established
45. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
46. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
IgE in Allergic Disease
• Total serum IgE levels related to the probability of an individual having detectable
allergen-specific IgE to common allergens
• Total serum IgE concentrations tend to be higher in adults and children with
allergic diseases compared with nonallergic individuals
• But measurement of total serum IgE concentrations is of limited value as a
screening test for allergic disease
47. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
IgE and Risk of Asthma
• Burrows and associates (1989): Relationship between the rates of self-reported
asthma and the total serum IgE concentrations was stronger than the relationship
between asthma rates and skin test reactivity to a battery of common allergens
• Sunyer and associates (1996): Total serum IgE concentrations of 100 IU/mL or
higher, the odds ratio for asthma was 4.7 compared with those with lower IgE
levels
• Forester (2010): Significantly increased numbers of mast cells and macrophages
bearing high-affinity IgE receptors (FcεRI) in bronchial biopsies from allergic and
nonallergic asthmatics
48. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
• Anti-human IgE monoclonal antibody, omalizumab: treatment of allergic asthma in
individuals 12 years old and older
• IgE levels cannot be measured accurately after treatment with omalizumab
• Total IgE levels increase for several months after the initiation of omalizumab
therapy, then decline to very low levels
IgE and Risk of Asthma
49. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
Total serum IgE levels are of clinical value in ABPA
• Elevated serum IgE level (>416 IU/mL [1000 ng/mL]) is one of the diagnostic
criteria for this condition
• IgE - follow the course of disease ( in disease successfully treated with
glucocorticoids, in disease exacerbate)
• Association between disease activity and levels of anti-Aspergillus IgE antibodies
• Several studies suggested that treatment of ABPA with omalizumab is effective in
controlling the disease, significantly lower doses of oral corticosteroids
Allergic Bronchopulmonary Aspergillosis
50. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
• Treating allergic patients with oral corticosteroids can reduce serum total serum
IgE concentrations?
• Study of 10 adults with allergic asthma with 20 mg of oral prednisone given twice
daily resulted in increased IgE concentrations in all 10 individuals
• Serum IgG levels were unchanged
IgE and Risk of Asthma
51. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
• Gross elevation of serum IgE helpful in distinguishing tropical pulmonary eosinophilia
from some other causes of pulmonary symptoms associated with eosinophilia, such as
Churg-Strauss syndrome and Wegener granulomatosis
Tropical Pulmonary Eosinophilia
52. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
IgE and Lung Function
• Relationship between total serum IgE levels and lung function complicated by asthma
and cigarette smoking and IgE concentrations
• Several studies have suggested that higher total serum IgE levels are associated with a
more rapid decline in lung function with advancing age
• Significant inverse association was found between IgE levels and lung function
53. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
IgE in Cord Blood
54. IgE in Cord Blood
Jeff Stokes, et al. UpToDate 2019.
• Attempt to identify newborns at increased risk for the development of allergic
disease
• Maternal IgE does not normally cross the placenta, although fetal cord blood can be
contaminated by maternal blood during late pregnancy and delivery and must be
carefully collected
Majority of studies suggest that total IgE in cord blood indicator of higher risk:
• Newborns with elevated cord IgE levels had an increased risk of developing
urticarial food reactions at 1 year of age, atopic dermatitis by 2 years of age,
allergen sensitization and wheezing at 7 years of age, or allergic rhinitis by 11 and
20 years of age
• However, no relationship was found between cord blood IgE levels and the
development of asthma, allergic rhinitis, or atopic dermatitis by the time the child
was 18 to 21 years of age despite a modest association with total IgE levels at
those ages in another study
55. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
Detection of Allergen-Specific IgE
Clinical value
• Predictive value of food-specific IgE antibody levels and positive results for food
challenges
• But relationship between inhalant allergy-specific IgE and symptoms is not as
robust
Specific IgE concentrations vary according to:
• Age
• Degree and duration of the most recent allergen exposure
• Degree and duration of exposure to cross-reactive allergens
• Immunotherapy
56. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
Indications for Measuring Specific IgE
• Association between presence of detectable allergen-specific IgE (determined by
positive skin test results or IgE antibody measurements) with allergic symptoms is
inconsistent results of tests for allergen-specific IgE are clinically valuable only
when considered in the context of a patient’s history
• In vitro tests are not as sensitive as skin tests
• Skin tests have lower time and reagent costs
• Detection of cross-reactive IgE antibodies potential problem with in vitro tests
57. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
58. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
IgE in Infectious Disease
Viral Infections
• Welliver and colleagues (1986): RSV - Peak IgE-RSV titers during acute infection were also
significantly associated with the risk of recurrent wheezing episodes during a 4-year follow-up
study (difficult to reproduce)
• IgE antibodies formed in some individuals after viral infections and immunizations
• Studies of mononucleosis related to EBV infection - initial rise in IgE concentration for 7-10
days, followed by decline and then a return to baseline levels over a course of weeks to
months
• Skoner and coworkers (1995): rhinovirus infections in adults with allergic rhinitis acutely
produced highly significant increase in total serum IgE levels
• Increased serum IgE reported in patients with human immunodeficiency virus type 1 (HIV-
1) infections and remarkably high incidence of allergic reactions to drugs and environmental
allergens
59. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
IgE in Infectious Disease
Bacterial Infections
• IgE specific for S. aureus exotoxins usually found in patients with HIES
• Anti-staphylococcal toxin IgE may be related to various allergic diseases,
especially nasal polyps and chronic rhinosinusitis
• Children develop IgE antibodies specific for pertussis and tetanus toxoids after
immunization but do not have major clinical significance
60. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
IgE in Infectious Disease
Yeasts and Fungi
• IgE antibodies specific for Candida albicans infection can be detected, and may
be increased in individuals with atopic dermatitis
• IgE antibodies to yeast Pityrosporum ovale found in people with atopic dermatitis
of the head, face, and neck
61. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
IgE in Infectious Disease
Parasitic Diseases
• Increased IgE levels occur during helminth parasitic infections
• Association between increasing levels of tissue invasion and increasing levels of
IgE
• Secretion by parasites of factors that stimulate production of IL-4 or IL-13, or both,
leading to increased IgE levels
• Total serum IgE levels fall after successful treatment
62. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
IgE in Nonatopic Disease
Neoplastic Disease
• Most direct relationship between IgE and neoplastic disease occurs with IgE
myeloma
• IgE concentrations at the time of diagnosis ranged from 0.6 to 63 g/L
• Strongest association between allergic sensitization and gliomas
• Hodgkin disease - serum IgE levels and fall with successful treatment
• Studies of forms of cancer other than Hodgkin disease have not revealed
consistent patterns of IgE elevation associated with the cancer or the response
to therapy
63. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
IgE in Nonatopic Disease
Transplantation
• serum IgE levels from 7 to 2000-fold in patients after bone marrow
transplantation
• IgE concentrations do not seem to result from myeloablative or
immunosuppressive therapy used in patients with neoplasia, seen in
immunodeficient children with bone marrow transplanted without myeloablative
therapy
• Many cases of new-onset allergic sensitization and disease after solid organ
(e.g., kidney, liver, lung) transplantation have been reported
• May related to specific immunosuppressive drugs
64. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
IgE in Nonatopic Disease
Renal and Liver Disease
• Total serum IgE levels in patients with nephrotic syndrome, glomerulonephritis,
minimal change disease, IgM nephropathy, focal glomerulosclerosis, and
membranous glomerulonephritis
• High IgE levels in nephrotic syndrome associated with decreased response to
steroid therapy
• IgE have also reported in liver disease
65. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
Environmental Exposure and IgE
Cigarette Smoking
• Serum IgE concentrations in smokers compared with nonsmokers and
intermediate concentrations in ex-smokers
• The effect of smoking on serum IgE levels greater in men > women
• Smoking workers are at increased risk for allergic sensitivity to certain
occupational allergens
• Results of various studies on the relationship of passive smoking with allergy
have been conflicting
• Tobacco smoke exposure increased allergen-specific IgE production
66. Philip H. Smith, et al. Middleton’s Allergy. 8th Ed.;2013:1108-18.
Environmental Exposure and IgE
Alcoholic
•Total IgE levels are increased in atopic and nonatopic alcoholics
Diesel Exhuast
• In vivo and in vitro studies showed a direct effect of diesel exhaust particles on
IgE production in mice, particles acted as an adjuvant for IgE production
• Increase in intranasal cytokine production, including IL-4, IL-5, IL-6, and IL-10
• Exposure to diesel exhaust particles and air pollutants may alter local nasal IgE
production
Animal Exposure
67. Take Home Messages
Measures of total IgE levels - not useful in diagnosis of allergic diseases because
of wide range of normal concentrations
With half-life of 2 to 5 days, serum IgE can change in days or weeks from
changes in balance of Th1, Th2, and regulatory T cell
Changes can result from a wide variety of exposures, including allergens, viral
infections, medications, and tumors
Measurements of allergen-specific IgE - useful in diagnosis of allergic disease
when interpreted in the context of medical history
Function IgE from…Treatment of allergic individuals with the humanized monoclonal anti-IgE antibody omalizumab
Function IgE from…Treatment of allergic individuals with the humanized monoclonal anti-IgE antibody omalizumab
. In addition, because a positive test gave rise to a wheal, it seemed likely that the high-affinity receptor for reagin was on a cell that contained histamine.
. In addition, because a positive test gave rise to a wheal, it seemed likely that the high-affinity receptor for reagin was on a cell that contained histamine.
Evolution
activation-induced cytidine deaminase (AID)
However, direct switching of B cells from IgM to IgE also occurs and may be the predominant isotype switching mechanism at mucosal sites
One clinical observation often cited as evidence for such a process is the known presence of allergen- specific IgE antibodies in the nasal secretions of patients with seasonal rhinitis but negative skin tests for the same allergen
These include the detection of the essential components of isotype switch machinery (IL-4, CD40L, and/or BAFF, another TNF family member capable of driving switching in B cells, and AID) as well as demonstration of the presence of ε-germline transcripts, switch excision circles, and IgE+ plasma cells.
As with other immunoglobulins, the IgE protein is a tetramer composed of two epsilon (ε) heavy chains and two kappa (κ ) or lambda (λ ) light chains.
N-terminal variable regions of the heavy (VH) and light (VL) chains create unique antigen- specific binding pockets
C-terminal constant regions of the ε heavy chains are made up of four Cε domains, each encoded by the Cε1-4 exons near the 3′ end of the immunoglobulin heavy chain locus (IgH). The four Cε domains confer the isotype-specific functions of IgE, including binding to its receptors FcεRI and CD23. Cε2 occupies the position comparable to the flexible “hinge” region contained in Cγ of γ heavy chains
X-ray crystallography of IgE-Fc fragments has revealed a sharp backward turn in the molecule in the Cε2-3 region so that the native conformation of IgE is compact and bent, unlike the more stretched-out and flexible structure of IgG
Figure 23-1 IgE structure and interaction with FcεRI.
Unlike IgG antibodies, whose γ heavy chains have three constant-region domains and a flexible hinge region, IgE antibodies have four constant-region
domains, Cε1-4 in their ε heavy chains. A sharp backward bend is conferred by Cε2 and Cε3, and Cε3 interacts with the IgE-binding α
chain of FcεRI. FcεRI exists in two conformations. The classic tetrameric form expressed on mast cells and basophils contains the IgEbinding
α chain in association with the β chain, a member of the tetraspanin family of four-transmembrane domain proteins, thought
to amplify signal transduction and a disulfide-linked dimer of γ chains important for signal transduction. A trimeric form of FcεRI, lacking the
β chain, is present on a number of other cell types, including Langerhans cells and dendritic cells.
Figure 23-2 T cell–B cell interactions leading to IgE isotype switching.
The signals driving isotype switching are provided during an ordered series of interactions between an antigen-specific Th2 cell and a B cell expressing immunoglobulin of the same antigenic specificity. An antigenspecific B cell (step 1) binds the antigen via surface immunoglobulins (sIgM), internalizes and processes it, and presents it to an allergen-specific Th2 cell as an MHC II–associated peptide fragment (2). Engagement of the T cell receptor (TCR) by the MHC II–antigen complex results in the initiation of cytokine transcription as well as the rapid expression of CD40L (CD154), which is not expressed on resting T cells (3). This in turn engages CD40, which is constitutively expressed on B cells (4). T cell–B cell signals mediated through CD40/CD40L are amplified by interactions between costimulatory molecules, particularly the CD28/CD80-CD86 ligand/receptor pair. Engagement of CD40 upregulates CD80-CD86
expression on B cells (5). CD80-CD86 then engages CD28 back on the T cell (6), strongly enhancing the cytokine transcription induced by TCR
signaling (7), resulting in secretion (8) of IL-4 and/or IL-13. Engagement of their receptors (9) provides the “cytokine signal” for isotype switching
and results in the activation of the transcription factor STAT6, which drives ε-germline transcription (εGLT) at the IgH ε locus (10). At the same
time, CD40 signaling activates NF-κB transcription factors, which induce expression of the enzyme activation-induced cytidine deaminase (AID),
which is recruited to the transcriptionally active ε locus and initiates the DNA recombination events (11) that lead to class switching and IgE
secretion (12).
Figure 23-3 Molecular events in IgE isotype switching.
Before switching occurs in a B cell, the immunoglobulin heavy chain (IgH) locus is in its germline configuration, with exons encoding the heavy chain constant-region domains distributed over about 150 kb of genomic DNA. However, VDJ recombination has already occurred, thus determining the antigen specificity of the antibody (1). Stimulation with IL-4 or IL-13 (2) results in the transcriptional activation of the IgE locus (3). The process of ε-germline transcription targets the locus for recruitment of the enzyme AID, induced by CD40 engagement (4) and this activates class switch recombination. DNA double-strand breaks followed by ligation of the targeted S regions generates chimeric Sμ/Sε regions composed of the 5′ Sμ joined to the 3′ portion of the targeted Sε region (5). During recombination, the intervening genomic DNA between Sμ and Sε is deleted as a switch excision circle (6).
Cross-linking of FcεRI-bound IgE by polyvalent allergens triggers membrane fusion of mast cell granules, with resul- tant exocytosis of preformed mediators of immediate hypersen- sitivity, such as histamine, and also induces rapid de novo synthesis of lipid mediators, such as prostaglandins and leukotrienes. Receptor activation also induces a specific program of gene transcription, leading to cytokine and chemokine secretion several hours later.
Although none of the component chains of FcεRI has inherent enzymatic activity capable of inducing tyrosine phosphorylation or cleaving membrane phospholipids, activation of the receptor is known to activate a number of SRC-family kinases (e.g., LYN, FYN, ZAP-70, SYK), all shown to be required for receptor function.
Figure 23-7 Early events in FcεRI signaling. The Cε2 and Cε3 domains of the IgE ε-heavy chain are bound to the α chain of FcεRI. On interaction
of receptor-bound IgE with polyvalent allergen, aggregation of the receptor allows the protein tyrosine kinase LYN (constitutively associated)
to transphosphorylate tyrosine residues in the immunoreceptor tyrosine-based activation motifs (ITAMs) on the β and γ chains of neighboring
FcεRI molecules (1). This generates docking sites for SYK, the key early kinase of FcεRI signaling (2). SYK is then activated by phosphorylation
and in turn phosphorylates the membrane-associated scaffold protein LAT, leading to the recruitment a number of signaling intermediates and
assembly of a macromolecular signaling complex (3). One of these intermediates, phospholipase Cγ (PLCγ), hydrolyzes the membrane lipid
phosphatidylinositol 4,5-bisphosphate (PIP2) to generate inositol 3,4,5-trisphosphate (IP3) and diacylglycerol (DAG) (4). DAG activates protein
kinase Cγ (PKCγ) (5), an enzyme that triggers signaling cascades, leading to degranulation and transcriptional activation. IP3 acts on the endoplasmic
reticulum (ER), leading to release of Ca2+ stores into the cytosol (6). Once ER stores are depleted, the ER protein STIM1 interacts with
calcium release–activated Ca2+ (CRAC) channels in the plasma membrane to induce the influx of extracellular Ca2+ (7). Recruitment of the GTP
exchange factors VAV and SOS to the signaling complex (via Grb2) activates RAS and its downstream pathways, driving cytoskeletal changes,
degranulation, and gene expression (8). Activation of the Rho family GTPase, Cdc42, by VAV (associated through the linkers Gads and SLP76,
which also recruit Bruton tyrosine kinase, BTK), induces activation of the Arp2/3 complex by the Wiskott-Aldrich syndrome protein (WASP) with
resultant actin polymerization and cytoskeletal changes (9).
The antigen-binding domains of the ε–heavy chain V regions may exist in equilibrium, and while one binds tightly to the nominal antigen for which the IgE is known to be specific, others may have significant affinity for unrelated, ubiquitously expressed autoantigens
The earliest evidence for IgE-independent pathways of hypersensitivity came from observations by Prausnitz in Germany a century ago that a heat- stable component of the γ-globulin fraction of serum could passively transfer cutaneous sensitivity. This was in contrast to the classic reagin, subsequently identified as IgE, whose activity was destroyed by heating for 1 hour at 56° C. The heat-stable fraction was ultimately identified as IgG, and in contrast to IgE- mediated reactions, the IgG response was short in latency. IgG injected into the skin is not as tightly bound to FcγRs as IgE is to FcεRI, which has much greater affinity. Thus, IgG diffuses away with resultant loss of sensitivity, while IgE is retained, and its sensitizing effect persists for weeks.
IgE knockout (IgE− /− ) mice was the very low density of FcεRI present on their mast cells and basophils
FcεR1 continues to be synthesized within a cell, the presence of ambient IgE favors the capture and accumulation of FcεRI at the cell surface.
ADAM (a disintegrin and metalloproteinase)
ADAM (a disintegrin and metalloproteinase)
Figure 23-8 Structure and function of CD23, a member of the C-type lectin family of proteins and a type II transmembrane protein with an
intracellular N terminus.
CD23 is expressed as an oligomer of coiled-coiled stalks bearing lectin-domain heads, which bind to the Cε3 and Cε4
domains of IgE. Protease sites in the stalks can be accessed by both endogenous (ADAM) and allergen (Der p 1) proteases to give rise to soluble
CD23 fragments (sCD23), which retain their IgE-binding properties. Functions of CD23 are illustrated in the lower panels. CD23 serves to facilitate
transepithelial allergen transport in gastrointestinal and respiratory epithelium. CD23 on B cells and antigen-presenting cells can mediate
antigen uptake for more efficient processing and presentation of antigenic peptides complexed to MHC class II molecules to the T cell receptor
(TCR) of specific T cells. CD23 regulates IgE production in B cells, with the transmembrane form suppressing IgE production (red arrows) and
soluble CD23 enhancing IgE responses (green arrows), perhaps by coligating membrane IgE on IgE+ B cells with CD21.
Conclusions
IgE is unique among immunoglobulin isotypes by virtue of possessing an extra Fc domain. Residing primarily in tissues bound to cell surface receptors, IgE is capable of using the extremely sensitive FcεRI high-affinity receptor and its bio- amplified signaling pathways to elicit intense hypersensitivity reactions to minute amounts of antigen. At the same time, IgE serves to regulate the induction of immune responses to anti- gens at mucosal surfaces, using the low-affinity receptor CD23 to facilitate their transepithelial transport and their uptake and processing by antigen-presenting cells. The coevolution of IgE antibodies with its receptors, as well as several committed effec- tor cell lineages responding to IgE with distinct functional pro- grams, indicate that this intricate and tightly orchestrated system confers a selective advantage. IgE likely developed to control host-parasite interactions. However, studies over the past decade have shown that in addition to activating mecha- nisms of host defense, IgE antibodies regulate immune homeo- stasis at a number of levels, modulating expression of their own receptors, enhancing antigen uptake and presentation, and sus- taining mast cell survival in mucosal tissues. As the use of anti- IgE therapies continues to expand, mechanistic studies will provide additional insights on IgE biology.
“Classical” solid phase allergen-specific IgE immunoassays (Figure 1B) are designed to bind all antigen-specific antibodies, and non-allergen binding components are then removed with buffer washes. Specific IgE antibody is detected by labeled anti-IgE antibodies. With the limited amount of antigen that can be immobilized on certain solid phase matrices (e.g. chip), this assay format will be affected by competitive inhibition by allergen-specific IgG that occurs in high titers following allergen-specific immunotherapy. With molar excess of antigen, this assay format is less prone to IgG-antibody inhibition.
Fluid phase allergen-specific IgE immunoassays (Figure 1C) can offer quick antibody binding kinetics but their robustness to interference from non-IgE specific antibodies also depend on the amount of applied allergen reagent.
Reverse type allergen-specific IgE immunoassays initially bind the entire IgE repertoire with immobilized anti-IgE Fc (Figure 1D). Following a buffer wash, bound allergen-specific IgE is then detected with a labeled allergen reagent. The assay is not adversely impacted by IgG-inhibition, but it has limitations in the case of very high total serum IgE levels that can exceed the anti-IgE binding capacity and thus produce potentially falsely low results.
Normal Immunoglobulin E Production
IgE antibody production is normally highly regulated, resulting in minimal IgE concentrations in body fluids.2 Most of the IgE-producing plasma cells are found in the lymphoid tissue associated with the gastrointestinal and respiratory tracts. The highest concentrations of IgE-producing plasma cells have been found in the tonsils and adenoids.
IgE production has been observed as early as 11 weeks in human fetal tissue cultures, but determination of how early in gestation a fetus becomes capable of producing IgE antibodies is complicated by a low rate of diffusion of maternal IgE into the amniotic fluid
<1% of cord serum samples contain detectable IgE antibodies to common allergens, and some of the detected allergen-specific IgE may be of maternal origin, but allergen-specific IgE rarely has been demonstrated in cord serum when IgE antibodies to the same allergen were not detectable in the mother’s serum
Polymorphisms of CCL11 (i.e., eotaxin) also appear to be associated with total IgE, with one nucleotide eotaxin polymorphism variant associated with increases in African American families and other polymor- phism variants associated with lower total IgE levels in whites.
Polymorphisms of CCL11 (i.e., eotaxin) also appear to be associated with total IgE, with one nucleotide eotaxin polymorphism variant associated with increases in African American families and other polymor- phism variants associated with lower total IgE levels in whites.Questions have arisen about “undetectable” or “absent” serum IgE levels.
Many individuals allergic to pollens have detectable IgE antibodies to foods, and 20% to 30% of those with food-specific IgE antibodies do not report symptoms related to foods. Many of the pollen-food cross- reactions may result from profilin, a highly conserved molecule among plants. Cross-reactive antibodies between foods and latex allergens also complicate the interpretation of in vitro tests for latex specific IgE antibodies.
The low frequency of IgE myelomas presumably reflects the small number of IgE-producing cells normally present in the body
Some IgE myelomas might have been missed because the quantity of IgE produced by the myeloma might have been less than that detectable by routine screening tests for myelomas, or they might have been misclassified as light-chain disease.
Initially, the increased IgE levels were thought to result from graft-versus-host disease, but subsequent studies showed that IgE levels also increased in patients who did not have graft- versus-host disease